Escherichia coli possesses three SOS-inducible DNA polymerases (Pol II, IV, and V) that were recently found to participate in translesion synthesis and mutagenesis. Involvement of these polymerases appears to depend on the nature of the lesion and its local sequence context, as illustrated by the bypass of a single N-2-acetylaminofluorene adduct within the NarI mutation hot spot. Indeed, error-free bypass requires Pol V (umuDC), whereas mutagenic (؊2 frameshift) bypass depends on Pol II (polB). In this paper, we show that purified DNA Pol II is able in vitro to generate the ؊2 frameshift bypass product observed in vivo at the NarI sites. Although the ⌬polB strain is completely defective in this mutation pathway, introduction of the polB gene on a low copy number plasmid restores the ؊2 frameshift pathway. In fact, modification of the relative copy number of polB versus umuDC genes results in a corresponding modification in the use of the frameshift versus error-free translesion pathways, suggesting a direct competition between Pol II and V for the bypass of the same lesion. Whether such a polymerase competition model for translesion synthesis will prove to be generally applicable remains to be confirmed. NarI mutation hot spot ͉ translesion synthesis ͉ slippage mutagenesis ͉ N-2-acetylaminofluorene ͉ umuDC (Pol V) P oint mutations are formed during DNA replication either as genuine replication errors or as a consequence of the presence of damage in the parental DNA. By changing the chemical structure of the bases, damaging agents are often effective blocks to the progression of replicative DNA polymerases. It has now become clear that these blocks are overcome by specialized enzymes (translesional DNA polymerases) that can read through damaged bases in a process known as translesion synthesis (TLS) (1-5). Because of the presence of the lesion, this process is inevitably less accurate than normal replication and will thus trigger increased mutation rates in the newly synthesized strand opposite the damaged base.
Escherichia coli possesses three SOS-inducible DNA polymerases (Pol II, IV, and V) that were recently found to participate in translesion synthesis and mutagenesis. Involvement of these polymerases appears to depend on the nature of the lesion and its local sequence context, as illustrated by the bypass of a single N-2-acetylaminofluorene adduct within the NarI mutation hot spot. Indeed, error-free bypass requires Pol V (umuDC), whereas mutagenic (؊2 frameshift) bypass depends on Pol II (polB). In this paper, we show that purified DNA Pol II is able in vitro to generate the ؊2 frameshift bypass product observed in vivo at the NarI sites. Although the ⌬polB strain is completely defective in this mutation pathway, introduction of the polB gene on a low copy number plasmid restores the ؊2 frameshift pathway. In fact, modification of the relative copy number of polB versus umuDC genes results in a corresponding modification in the use of the frameshift versus error-free translesion pathways, suggesting a direct competition between Pol II and V for the bypass of the same lesion. Whether such a polymerase competition model for translesion synthesis will prove to be generally applicable remains to be confirmed. NarI mutation hot spot ͉ translesion synthesis ͉ slippage mutagenesis ͉ N-2-acetylaminofluorene ͉ umuDC (Pol V) P oint mutations are formed during DNA replication either as genuine replication errors or as a consequence of the presence of damage in the parental DNA. By changing the chemical structure of the bases, damaging agents are often effective blocks to the progression of replicative DNA polymerases. It has now become clear that these blocks are overcome by specialized enzymes (translesional DNA polymerases) that can read through damaged bases in a process known as translesion synthesis (TLS) (1) (2) (3) (4) (5) . Because of the presence of the lesion, this process is inevitably less accurate than normal replication and will thus trigger increased mutation rates in the newly synthesized strand opposite the damaged base.
Recently it was shown that in Escherichia coli, all three SOS-inducible DNA polymerases, Pol II (polB), Pol IV (dinB), and Pol V (umuDC), can be involved in TLS, depending on the nature of the DNA damage and its sequence context (6) . We have identified an intriguing situation where the bypass of a given lesion, N-2-acetylaminofluorene (AAF), located within a frameshift mutation hot spot, the NarI site, is mediated by two genetically distinct pathways. Indeed, in that sequence context, the bypass of an AAF guanine adduct requires Pol V for nonslipped elongation, yielding error-free TLS but Pol II for slipped elongation, thus producing Ϫ2 frameshift TLS (6) . The nonslipped TLS pathway obeys the rules previously described for base substitution mutagenesis induced by UV light or abasic sites, i.e., Pol V and RecA* dependence (for a recent review, see ref. 7) . In contrast, the involvement of DNA Pol II in the slipped Ϫ2 frameshift pathway is more intriguing. Although a series of phenotypes related to DNA repair have been described in polB strains (8) (9) (10) (11) (12) , only one study has pointed to the potential role of the polB gene product in the bypass of abasic sites in vivo (13) .
In this paper, we show that purified DNA Pol II is able in vitro to generate the Ϫ2 frameshift bypass product observed in vivo at the NarI sites. Moreover, we analyze in vivo the relative utilization of the Pol II versus Pol V pathways on introduction into the ⌬polB strain of the polB gene on a low copy number plasmid and show that the two polymerases compete for elongation of the same replication intermediate.
Experimental Procedures
Construction of polB (exo؉ and exo؊) Expression Vectors. The coding sequence of the polB gene was amplified by PCR from genomic DNA isolated from strain MG1655. The natural but ''inefficient'' GTG translation initiation codon was changed to ATG during PCR amplification. The corresponding 2.4-kb PCR product was first purified after agarose gel electrophoresis and inserted into the pCAL-n-FLAG expression vector (Stratagene). The selected recombinant plasmids pCAL-n-FLAG-polB were digested and partially sequenced to confirm the identity of the 2.4-kb insert. An exoϪ version of the polB gene containing two substitutions (D155A and E157A) in the Exo I motif was engineered by using standard oligonucleotide site-directed mutagenesis. The expected mutations were confirmed by sequencing.
final. The eluted fractions were pooled and dialyzed against buffer C (50 mM Tris⅐HCl, pH 8.0͞50 mM NaCl͞2 mM CaCl 2 ͞0.1% Tween-20). Protein concentration was determined by the Bradford assay. Native DNA Pol II was obtained by proteolytic cleavage of 200 g of CBP-tagged Pol II with 2 units of enterokinase (Stratagene) in buffer C at 4°C overnight. DNA Pol II was stored in buffer D (50 mM Tris⅐HCl, pH 8.0͞200 mM NaCl͞5 mM DTT͞50% glycerol) at Ϫ80°C. The Pol II exoϪ protein was expressed and purified in a similar way. Both purified DNA Pol II exoϪ and exoϩ preparations appear as a single polypeptide of Ϸ90 kDa (purity was estimated to be Ն95%) on 8% SDS͞PAGE after Coomassie blue staining.
Determination of DNA Pol II Specific Activity. The specific activity of native Pol II was measured by using a classical incorporation assay with a mixture of all four dNTPs at 100 M final containing ␣- P-dCTP into insoluble material in 1 min at 37°C.The specific activity of our preparation of native wild-type Pol II was found to be 1.5 ϫ 10 4 units͞mg, in good agreement with the previously published value (14) . The specific activity of Pol II exoϪ was 3-fold lower than that of the wild-type Pol II, suggesting that the D155A and E157A substitutions cause a small reduction in enzyme activity (14) . No 3Ј-5Ј exonuclease activity was detected with Pol II exoϪ.
Oligonucleotide Primer͞Templates. Oligonucleotides containing a single T(6-4)T photoproduct or a single G-AAF adduct within the 3G or the NarI sequence context have been described previously (15) (16) (17) . To serve as templates in primer extension reactions, these oligonucleotides were extended by ligation on their 3Ј-ends to a common 55-mer oligonucleotide by using complementary scaffold oligonucleotides generating the series of ''70-mer'' templates. Similarly a series of ''90-mer'' templates was constructed by simultaneous ligation of a 20-mer and a 55-mer onto the 5Ј and 3Ј ends of the lesion containing oligonucleotide. Annealing of the scaffold, ligation, and subsequent purification by PAGE of the ligation product were done as described previously (18) (19) (20) . After purification, these 70-or 90-mer template oligonucleotides are annealed to a 24-or 20-mer primer that is complementary to the 55-mer oligonucleotide common to all templates. Sequences of the oligonucleotides templates (70 mers): NarA AF template: 5ЈTAC-ACCGGCGCCACAGACTAAGCTTGGCACTGGCCGTC-GTTTTACAACGTCGTGACTGGGAAAACCCTGG3Ј, 3G template: 5ЈAATTCAGTCATACCCGGGACATCGACTA-AGCTTGGCACTGGCCGTCGTTTTACAACGTCGTGA-CTGGGAAAACCCTGG3Ј and T(6 -4)T sequence: 5ЈG-CAAGTTAACACGGACTAAGCTTGGCACTGGCCGTC-GTTTTACAACGTCGTGACTGGGAAAACCCTGG3Ј (target site is underlined). Twenty mer used in the construction of the 90 mers: 5ЈCCATGATTACGAATTCAGTC3Ј.
Primer Extension Reactions. All reactions were conducted at 30°C in the following buffer: 20 mM Tris⅐HCl (pH 8.0)͞10 mM MgCl 2 ͞5 mM DTT͞1 mM ATP͞0.1 mg͞ml BSA͞dATP, dTTP, dGTP, dCTP each at 200 M final. Amounts of primertemplate, single-strand-binding protein (SSB), and polymerase are specified in the legend of the figures. Klenow fragment (exoϪ) was purchased from New England Biolabs. Reactions were terminated by the addition of 4 vol of formamide containing 20 mM EDTA and bromophenol blue. The reaction mixtures were heat denatured, electrophoresed on 12 or 15% denaturing (8 M urea) polyacrylamide gels, and visualized by using a PhosphorImager 445SI (Molecular Dynamics). The identity of given replication products was established after recovery of the product from the gel and sequencing by means of the Thermo Sequenase Radiolabeled Terminator Cycle Sequencing Kit (Amersham Pharmacia).
Bacterial Strains and Plasmids. E. coli strain MGZ and its ⌬polB derivative have been previously described (6) . The polB gene expressed from its natural promoter͞operator region has been cloned into the low copy number vector pWKS130 derived from pSC101 (21) .
Determination of Error-Free and Mutagenic TLS in Vivo. The relative proportion of error-free and Ϫ2 frameshift TLS events were determined in vivo as described previously by using a plasmid with a single AAF adduct located within a NarI sequence 5Ј-GGCG AAF CC-3Ј in the N-terminal part of the lacZЈ gene of a pUC-derived plasmid (22, 23) . This construction, introduced into SOS-induced bacteria by electroporation, confers a LacZ Ϫ phenotype that can be reverted to LacZ ϩ by a Ϫ2 frameshift mutation (22, 23) . SOS induction was achieved by prior UV irradiation at a dose of 50 J͞m 2 , as previously described (24) . The fraction of Ϫ2 frameshift TLS events is determined as the fraction of blue colonies among all transformants on indicator plates containing carbenicillin, 5-bromo-4-chloro-3-indolyl ␤-Dgalactoside, and isopropyl ␤-D-thiogalactoside. Colonies resulting from either error-free TLS or damage avoidance events form white colonies on these plates. Among the white colonies, the fraction of colonies resulting from error-free TLS is determined by using the colony hybridization assay developed previously (22, 24) . The majority of colonies represent colonies where plasmid replication occurred via damage avoidance (22, 24, 25) .
Results
For the sake of clarity, we will define a few terms to characterize the process of TLS. A TLS reaction may be viewed as comprising at least two steps: (i) an insertion step, during which a nucleotide is incorporated in the newly synthesized strand across from the lesion. This step generates a key replication intermediate that we refer to as the lesion terminus (LT) (26, 27) ; and (ii) one or several extension step(s) of the LT.
DNA Pol II Generates Frameshift Products During Bypass of an AAF
Adduct Located Within the NarI Site. All TLS reactions are performed by using synthetic primer͞template oligonucleotides. Primers are designated as Ln, n being the number of nucleotides between the 3Ј-end of the primer and the lesion site L. For example, L0 and L-6 refer to primers whose 3Ј end is located across and six nucleotides upstream from the lesion site, respectively.
A template oligonucleotide containing a single AAF adduct located at G 3 within the NarI site (G 1 G 2 CG 3 AAF CC) was annealed to primer L-6 and incubated with DNA Pol II. Primer elongation products are visualized on sequencing gels. In addition to a strong stop at position L-1, both partial and complete bypass products were observed in the presence of DNA Pol II (Fig. 1A) . Compared with the lesion-free control template, no full length replication product is obtained with the AAFcontaining template. Instead, two bypass products of similar intensities, respectively one and two nucleotides shorter than the full length products, are observed (Fig. 1 A) . The sequence of the (Ϫ1) and (Ϫ2) bypass products was determined. The (Ϫ2) bypass product is the expected NarI frameshift mutation resulting from C incorporation across G-AAF followed by a twonucleotide slippage reaction (i.e., GGCG AAF CC3 GGCC), whereas the (Ϫ1) product is ''compatible'' with misincorporation of G across G-AAF, followed by a one-nucleotide slippage reaction (GGCG AAF CC3GGGCC), as described in the scheme below (Scheme 1). The Ϫ1 product may also be produced if Pol II ''skips'' over the G-AAF adduct via a dNTP stabilized loopedout structure (28, 29) . TLS experiments described above, involving primer L-6, are generally referred to as ''running start'' reactions. By using primer L-1, i.e., ''standing start'' conditions, a similar bypass pattern involving the formation of both (Ϫ1) and (Ϫ2) TLS products is also observed (data not shown). In contrast, when Pol II is used for the extension reaction, with primer L0, only the (Ϫ2) bypass product is formed (see below).
Similar TLS reactions were conducted by using a single G-AAF adduct located within a different sequence context, namely within sequence 5Ј-CG 1 G 2 G 3 A-3Ј, a sequence previously identified as a Ϫ1 frameshift mutation hot spot (16, 30, 31) . The AAF adduct was located either at G 1 or G 3 positions. With both substrates, elongation of the corresponding primer proceeds to the position preceding the lesion site (L-1) forming a strong block ( Fig. 1 B and C) . No incorporation across or beyond the lesion site is seen ( Fig. 1 B and C) . These results are in agreement with the genetic data showing that Pol II is involved neither in error-free nor mutagenic bypass of AAF adducts within this sequence context (6) . Indeed, Pol V (umuDC) mediates these bypass reactions (6, 24) . Similarly, replication of an oligonucleotide containing a single T(6-4)T photoproduct shows that Pol II elongates the primer to the position preceding the 3Ј-T of the photoproduct, without incorporation across or beyond the lesion site (Fig. 1D) . These results are also in agreement with the in vivo data, as Pol V was shown to be required in the bypass of T(6-4)T lesions (6, 15) .
Characterization of the Frameshift Replication Intermediate Formed
During the Bypass of an AAF Adduct by DNA Pol II. Extension experiments were carried out with a primer͞template substrate that mimics the LT. The 3Ј-end of the primer was located across from the lesion site (primer L0) with a C residue across from the G-AAF adduct, as it was shown both in vivo and in vitro that most of the time G-AAF adducts ''correctly'' direct the insertion of cytosine (26, 32) . Pol II is able to extend this intermediate generating exclusively bypass product two nucleotides shorter than the one obtained with the lesion-free control template (Fig. 2) . Sequencing of the (Ϫ2) bypass product reveals that TLS occurred with the loss of a CpG dinucleotide (5Ј-GGCGCC35Ј-GGCC), strongly suggesting the elongation of a two-nucleotide slippage intermediate (Fig. 5) . The capacity of wild-type Pol II to specifically extend such an unusual primer terminus is surprising in view of its robust 3Ј-5Ј exonuclease activity (see discussion below) (14) . In fact, an exonucleasedeficient mutant of Pol II (D155A and E157A in the ExoI motif) yields a similar amount of (Ϫ2) bypass product (Fig. 2) . We have no explanation for the presence of a pause site at L ϩ 1 for both modified and unmodified substrates with the Pol II exoϪ enzyme. The exoϪ Klenow fragment is unable to extend this replication intermediate.
For further insight into the mechanism of the Ϫ2 bypass reaction, we conducted extension reactions by using only one or a combination of two dNTPs. Extension of primer L0 annealed to the lesion-free control template gave the expected results (Fig. 3) . With dGTP or a combination of dGTP and either dTTP or dATP only one nucleotide, (G) is incorporated (Fig. 3A, lanes 12-14) . With a mixture of dGTP and dCTP, a five-nucleotide extension of the primer is observed, as expected from the template sequence (Fig.  3A, lane 11) . With the AAF-containing template, no extension of the primer is observed when incubated with dGTP or a combination of dGTP and either dTTP or dATP (Fig. 3, lanes 7-9) . In contrast, when incubated with dCTP or a combination of dCTP and dTTP or dATP, a one-nucleotide extension reaction is observed (Fig. 3A, lanes 2-4) . With dGTP and dCTP, the primer is elongated by three nucleotides (Fig. 3A, lanes 1 and 6) . The specificity of the observed extension reaction is compatible with the formation of a slipped primer͞template intermediate, as shown in Fig. 3B . The 5Ј-GpC extremity of the primer has slipped onto the complementary 5Ј-GpC sequence that resides next to the G-AAF adduct on the template strand. As a result, the 5Ј-G AAF pC dinucleotide in the template strand remains unpaired. We have previously shown that the G-AAF adduct stabilizes such a slipped structure by virtue of stacking interactions between the aromatic AAF moiety with the adjacent bases (33) (34) (35) . We suggest that the LT can adopt two conformations. In the nonslipped conformation, the 3Ј-end of the primer is likely to be ''breathing'' because of the presence of the G-AAF adduct in the template strand. Indeed, AAF adducts have been shown to induce local opening of double-stranded DNA (described as the Insertion Denaturation Model) (36, 37) . In contrast, in its slipped conformation, the 3Ј-end of the primer forms two correct GC base pairs at its extremity. This particular structure of the primer͞template appears to be efficiently extended by Pol II, thus generating Ϫ2 frameshift mutations. The stability of the primer terminus that is brought about by the two terminal GC base pairs in the slipped intermediate may be enough to prevent the proofreading reaction.
Expression of Pol II from a Low Copy Number Plasmid Complements the
Defect in NarI Mutagenesis of a ⌬polB Strain. To check whether the expression of Pol II is able to restore NarI frameshift mutagenesis in a ⌬polB strain, we cloned the wild-type polB ϩ gene expressed from its natural SOS-controlled promoter into a low copy number plasmid (pWKS130) derived from pSC101 (four to eight copies͞ cell) (21) . The resulting plasmid pWKS-polB ϩ , or the control vector pWKS130, was introduced into a ⌬polB strain. TLS was analyzed in the resulting strains under SOS-induced conditions by using a vector with a single AAF adduct located within the NarI site, as described previously (6, 22) . This vector contains a small sequence heterology in the vicinity of the AAF lesion that serves as a genetic strand marker, allowing the quantitative determination of both error-free and mutagenic TLS under in vivo replication conditions (22, 24) . As expected from previous results, when comparing the wild-type strain to the ⌬polB strain containing the control vector, frameshift TLS was completely abolished, whereas error-free TLS remained mostly unaffected (Fig. 4) (6) . On introduction of the polB ϩ plasmid in the ⌬polB strain, mutagenic TLS increases from Ϸ0.1 to Ϸ40%, demonstrating that Pol II expression is sufficient to restore NarI frameshift mutagenesis (Fig. 4) . A drastic change in the TLS pattern is observed when comparing the wild-type strain containing one copy of the polB gene to the strain containing several copies of polB. Indeed, a strong increase in slipped frameshift TLS from Ϸ10 to Ϸ40% with a concomitant decrease in error-free TLS from Ϸ20 to Ϸ5% is observed (Fig. 4) . The potential biological meaning of this observation will be discussed below.
Discussion
To date, the genetics and biochemistry of lesion bypass have mostly been inferred from work with UV photoproducts and abasic sites as model lesions. Bypass of these lesions requires both the umuDC (Pol V) and recA gene products (38) . The bypass in E. coli of other replication-blocking lesions, such as adducts formed by polycyclic hydrocarbons and aromatic amides, has recently been shown to potentially involve all three SOSinducible DNA polymerases (Pol II, IV, and V) (6) .
We have identified a situation where the bypass of a given lesion, AAF, located within a frameshift mutation hot spot, the NarI site, is mediated by two distinct pathways: Pol V and II are required for nonslipped (error-free) and slipped Ϫ2 frameshift TLS, respectively (6) .
Biochemical Model of TLS at the NarI Site. Within the frame of the two-step model of TLS, both the insertion and extension step(s) present distinct challenges to polymerases. The insertion step entails the addition onto a nondistorted primer of a nucleotide across from a damaged template base, whereas the reverse situation occurs for the extension step(s), i.e., addition onto a distorted primer terminus of a nucleotide across from a nondamaged template position. One or a combination of several specialized DNA polymerases may perform the insertion and extension steps. Our data allow us to propose a model specifying the polymerases involved in vivo in the insertion and extension steps during the bypass of AAF within the NarI site.
Insertion
Step. In the present paper, we show that when Pol II is used to extend the LT, it is indeed able to generate exclusively the Ϫ2 TLS products that are observed in vivo. In contrast, when Pol II is used in the complete TLS reaction, involving both insertion and extension steps, both Ϫ1 and Ϫ2 TLS products are observed. That Ϫ1 frameshift mutations are not found at NarI sites in vivo (29, 39) suggests that the reaction leading to the Ϫ1 TLS product in vitro is not biologically relevant. Therefore, most likely, in vivo, Pol II is involved not in the insertion step but only in the extension step(s). The question remains as to which DNA polymerase(s) mediate(s) the insertion reaction in vivo? We have previously shown that Ϫ2 frameshift TLS is fully proficient in a ⌬dinB strains but is reduced by about 30% in a ⌬umuDC strain, suggesting thus Pol V but not Fig. 4 . Extent of error-free and Ϫ2 frameshift TLS events in vivo. Error-free and Ϫ2 frameshift TLS events measured in vivo in different SOS-induced strains: wt, wild type strain MGZ; ⌬polB, strain MGZ⌬polB; ⌬polB ϩ pWKS130, strain MGZ⌬polB transformed with pWKS130. ⌬polB ϩ pWKS-polB ϩ : strain MGZ⌬polB transformed with the corresponding polBϩ gene-expressing plasmid. 5 . Model for TLS pathways at an AAF adduct located within the NarI site. Two distinct pathways for the bypass of a single AAF adduct located within the NarI site can be defined. The nonslipped pathway yielding error-free TLS requires the SOS-inducible DNA Pol V and RecA* similarly to UV-induced base substitution mutagenesis pathway. In contrast, the slipped pathway that generates Ϫ2 frameshift mutations requires another SOS-inducible DNA polymerase, namely DNA Pol II. Both nonslipped and slipped pathways are of similar importance in a wild-type strain representing 17 and 10% of the replication events, respectively. In vivo and in vitro studies allow us to describe the individual steps involved in both pathways. Formation of the LT by insertion of C opposite the G-AAF adduct appears to be feasible by either Pol III or Pol V. This replication intermediate, common to both pathways, can adopt two conformations referred to as nonslipped and slipped conformations. The nonslipped conformation exhibits a distorted 3Ј-end of the primer, whereas in its slipped conformation, the primer forms two correct GC base pairs at its extremity. In vivo analysis of TLS reveals a competition between Pol V and II for the elongation of the nonslipped and slipped lesion termini, respectively.
Pol IV may act at the insertion step in vivo (6, 40) . However, as the effect of ⌬umuDC is only partial (30% reduction), we suggest that, in addition to Pol V, Pol III itself can perform the insertion step.
Extension
Step. Depending on its conformation, the same LT can be extended by two different DNA polymerases, generating distinct bypass products (Fig. 5) . In the nonslipped conformation, Pol V appears to be able to extend the LT despite the fraying of the 3Ј-end extremity of the primer yielding an error-free bypass product. This pathway appears to be similar to UV photoproduct or abasic site TLS pathways. In contrast, in its slipped conformation, when the primer template terminus exhibits two correct GC base pairs, TLS is mediated efficiently by Pol II yielding Ϫ2 frameshift mutations. It should be stressed that in wild-type E. coli, both pathways are of similar relative importance (Fig. 4) When the replicative DNA polymerase (Pol III) encounters a replication-blocking lesion, it is likely that it detaches from the primer terminus. However, the processivity clamp remains on the DNA and may act as a common plate-form for the recruitment of the translesional DNA polymerases. Indeed, the polymerase activity of Pol II (41), Pol IV (42), and Pol V (43) are known to be stimulated by the processivity clamp. Interestingly, an increase in the level of expression of Pol II relative to that of Pol V in vivo results in a corresponding increase in the amounts of slipped bypass with a concomitant decrease in nonslipped bypass (Fig. 4) . In fact, Pol II and V appear to compete for the extension of this LT. In the wild-type strain, Pol II and V pathways represent about 40 and 60% of the TLS events, respectively. In the ⌬polB strain, the Pol II pathway represents less than 1% of all TLS events. On introduction of the polB plasmid, the Pol II pathway amounts to 90% of all TLS events, whereas the Pol V pathway represents about 10%. Modulation of the extent of total TLS in the different strains reflects the competition between TLS and damage avoidance events.
Even if the situation described here is restricted to this particular combination of ''local sequence͞specific adduct,'' it nevertheless tells us that the ''classical'' TLS pathway involving DNA Pol V can be challenged by another DNA polymerase, namely by DNA Pol II. Current models of TLS propose that Pol V is positioned at the lesion site by means of a RecA͞single-stranded DNA filament (44, 45) . Our data suggest that the LT is available for Pol II extension (in its slipped conformation) in a reaction that competes with the Pol V͞RecA* pathway. Both prokaryotic and eukaryotic cells possess a pool of DNA polymerases, with relaxed specificities to deal with the large variety of existing DNA lesions. The specific role of the various DNA polymerases is not yet clear. Some polymerases may be specialized in the insertion step, whereas others are specialized in the subsequent extension steps. Moreover, as the gaps that are generated in vivo opposite replication blocking lesions are up to 1,000 nucleotides long (46) , the question also remains as to which DNA polymerase(s) performs the bulk of the gap-filling reaction. Whether a TLS model based on the competition among DNA polymerases (as suggested by the present work) will prove to be generally applicable remains to be further documented.
